Here, we also found that depletion of NEDD1 successfully lowered the levels of TGF‐β and IL‐10 in DLBCL cells and elevated the killing effects of T cells on the DLBCL cells. The gene discussed is IL10; the disease is diffuse large B-cell lymphoma.